Medtech Companies in Flowable Hemostats Market Cement Supply Chains to Ensure Access to Advanced Hemostatis for Surgeries, Valuation to Reach US$1 Bn by 2027: TMR
(0) - Healthcare companies harness hemostat technologies to improve surgical outcomes in orthopedics and cardiology, thrombin-gelatin hemostatic matrix gathers traction due to remarkable safety and efficacy - Tranexamic acid-loaded starch microspheres and novel hemostatic agents such as flowable procoagulants attract R&D interest, stringent regulations in key economies shape the contours of growth in flowable hemostats markets ALBANY, N.Y., Jan. 21, 2021 /PRNewswire/ -- Flowable hemostats are gaining popularity in clinical practice to meet the need of advanced hemostatis. They reduce time t...
Source: finanznachrichten.de